GOVERNANCE AND QUALITY 2021 saw a restructure and investment in Icon’s governance team to streamline study start-up framework and centralise support across feasibility, ethics and trial contracts. Newly appointed Global Research Governance Manager, Tenille Baker has brought a new level of expertise to the Group’s global governance procedures and has introduced an independent research governance quality framework for efficient review, compliance, and approval of all clinical research activity across the global network.
TENILLE BAKER
ELIZA KEATING
Global Research Governance Manager
Research Quality Specialist
Tenille brings over 20 years’ experience in
Eliza started her career in academic research
administration, clinical trials and research across
institutions with a strong interest in the field of
both the public and private sector. She has previously
oncology. She progressed to a Data Manager role
held national research and business operational
before taking the position of Research Quality
and research associate positions with a focus on
Specialist at Icon in July 2021. Her attention to
trial compliance, standardised ethics procedures
detail, clinical experience and academic background
and audits, and quality trial tracking and archiving
reflects the skills required for maintaining regulatory
procedures. Tenille is a certified TransCelerate
standards and compliance for oncology and
GCP trainer.
haematology clinical trials. Eliza leads evolutions for quality programs and systems across Icon Group to
Connect on LinkedIn
meet international expansion. Connect on LinkedIn
40
ICON ANNUAL RESEARCH REPORT 2021
